Boechat; Nubia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boechat; Nubia.The latest application filed is for "isatin-derived compounds, use of the compounds for the treatment of aids and method of treatment using these compounds".

Company Profile

2.5.7

Boechat; Nubia - Rio de Janeiro BR
Boechat; Nubia - Niteroi BR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Isatin-derived compounds, use of the compounds for the treatment of AIDS and method of treatment using these compounds Grant 10,538,515 - Boechat , et al. Ja	2020-01-21
Isatin-derived Compounds, Use Of The Compounds For The Treatment Of Aids And Method Of Treatment Using These Compounds App 20190177305 - BOECHAT; Nubia ; et al.	2019-06-13
Phenylaminopyrimidine-Derived Compounds, Method for Obtaining, Using Said Compounds in the Treatment of Cancer, and Treatment Methods App 20170226123 - BOECHAT; Nubia ; et al.	2017-08-10
Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine Grant 8,802,701 - Boechat , et al. August 12, 2	2014-08-12
Azole compounds used as tuberculostatic and leishmanicide agents Grant 8,796,316 - Boechat , et al. August 5, 2	2014-08-05
Azole Compounds Used As Tuberculostatic And Leishmanicide Agents App 20130274298 - Boechat; Nubia ; et al.	2013-10-17
Azole compounds used as tuberculostatic and leishmanicide agents Grant 8,436,027 - Boechat , et al. May 7, 2	2013-05-07
Azole Compounds Used As Tuberculostatic And Leishmanicide Agents App 20110269803 - Boechat; Nubia ; et al.	2011-11-03
Azole Compounds Used As Tuberculostatic And Leishmanicide Agents App 20090054501 - Boechat; Nubia ; et al.	2009-02-26
Compounds Derived From Lidocaine, Pharmaceutical Compositions, Use And Method Of Treatment, Prevention Or Inhibition Of Disease App 20080221206 - Martins; Marco Aurelio ; et al.	2008-09-11
Compounds Derived From Artesunate, Preparation Process, Pharmaceutical Composition And Use Of The Respective Medicine App 20070281968 - Boechat; Nubia ; et al.	2007-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.